Page last updated: 2024-11-02

oxidopamine and Obesity

oxidopamine has been researched along with Obesity in 2 studies

Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schwerk, A1
Altschüler, J1
Roch, M1
Gossen, M1
Winter, C1
Berg, J1
Kurtz, A1
Steiner, B1
Nobrega, JN1
Coscina, DV1

Other Studies

2 other studies available for oxidopamine and Obesity

ArticleYear
Human adipose-derived mesenchymal stromal cells increase endogenous neurogenesis in the rat subventricular zone acutely after 6-hydroxydopamine lesioning.
    Cytotherapy, 2015, Volume: 17, Issue:2

    Topics: Adipose Tissue; Adult; Animals; Brain-Derived Neurotrophic Factor; Cell Proliferation; Cell- and Tis

2015
Dopamine-norepinephrine interactions in the development of hyperphagia and obesity following medial hypothalamic lesions.
    Pharmacology, biochemistry, and behavior, 1986, Volume: 25, Issue:2

    Topics: Animals; Body Weight; Brain Mapping; Bupropion; Dopamine; Feeding Behavior; Female; Hydroxydopamines

1986